North American solar mounting manufacturer Opsun Systems Inc. has launched a commercial flat-roof racking solution engineered ...

Novocure has received the CE mark for Optune Pax, its portable medical device intended to treat adults with locally advanced ...

French electro-optical/infrared (IR) technology house HGH is to supply a variant of its SPYNEL 360° infrared (IR) ...

“The leading news in the quarter was the FDA approval and subsequent U.S. launch of Optune Pax for patients with locally advanced pancreatic cancer.” (Executive Chairman William Doyle) “In the 7 weeks ...

What is Optune Gio ® approved to treat? Optune Gio is a wearable, portable, FDA-approved device indicated to treat a type of brain cancer called glioblastoma multiforme (GBM) in adult patients 22 ...

Last month, the United States Food and Drug Administration (FDA) approved a new wearable device for treating pancreatic cancer. This device, called Optune Pax, sends alternating electric fields to the ...

Management issued guidance of $675 million to $705 million in net revenue for 2026, assuming Optune Gio net revenue growth in the low to mid-single digits and $15 million to $25 million in net revenue ...

Carolyn Gusoff has covered some of the most high profile news stories in the New York City area and is best known as a trusted, tenacious, consistent and caring voice of Long Island's concerns. For ...

In a phase 3 trial, Optune Pax plus gem/nab-pac significantly improved median overall survival to 16.2 months vs 14.2 months with chemotherapy alone. The Food and Drug Administration (FDA) has ...

Three years after being diagnosed with pancreatic cancer, Jeneen Genna, from East Islip, says the new FDA-approved device to treat pancreatic cancer will help people struggling to survive. "Any ...